J&J Joins Pharma Peers With $55bn In Manufacturing And Other US Spending
Trump Takes Credit For Domestic Production Boost
J&J followed in the footsteps of Lilly and Merck, which have announced multibillion-dollar investments in US manufacturing since Donald Trump’s inauguration.
